Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.

The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by dive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anne-Marie Carola Andersson, Kjell O Håkansson, Benjamin Anderschou Holbech Jensen, Dennis Christensen, Peter Andersen, Allan Randrup Thomsen, Jan Pravsgaard Christensen
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fcc58fe31204fd5913bf95deb263eb9
record_format dspace
spelling oai:doaj.org-article:9fcc58fe31204fd5913bf95deb263eb92021-11-18T08:13:33ZIncreased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.1932-620310.1371/journal.pone.0046395https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb92012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049700/?tool=EBIhttps://doaj.org/toc/1932-6203The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by diverse influenza A viruses, a vaccine (M2e-NSP4) was constructed linking M2e (in its consensus sequence) to the rotavirus fragment NSP4(98-135); due to its coiled-coil region this fragment is known to form tetramers in aqueous solution and in this manner we hoped to mimick the natural configuration of M2e as presented in membranes. M2e-NSP4 was then evaluated side-by-side with synthetic M2e peptide for its immunogenicity and protective efficacy in a murine influenza challenge model. Here we demonstrate that M2e fused to the tetramerizing protein induces an accelerated, augmented and more broadly reactive antibody response than does M2e peptide as measured in two different assays. Most importantly, vaccination with M2e-NSP4 caused a significant decrease in lung virus load early after challenge with influenza A virus and maintained its efficacy against a lethal challenge even at very low vaccine doses. Based on the results presented in this study M2e-NSP4 merits further investigation as a candidate for or as a component of a universal influenza A vaccine.Anne-Marie Carola AnderssonKjell O HåkanssonBenjamin Anderschou Holbech JensenDennis ChristensenPeter AndersenAllan Randrup ThomsenJan Pravsgaard ChristensenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 10, p e46395 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anne-Marie Carola Andersson
Kjell O Håkansson
Benjamin Anderschou Holbech Jensen
Dennis Christensen
Peter Andersen
Allan Randrup Thomsen
Jan Pravsgaard Christensen
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
description The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by diverse influenza A viruses, a vaccine (M2e-NSP4) was constructed linking M2e (in its consensus sequence) to the rotavirus fragment NSP4(98-135); due to its coiled-coil region this fragment is known to form tetramers in aqueous solution and in this manner we hoped to mimick the natural configuration of M2e as presented in membranes. M2e-NSP4 was then evaluated side-by-side with synthetic M2e peptide for its immunogenicity and protective efficacy in a murine influenza challenge model. Here we demonstrate that M2e fused to the tetramerizing protein induces an accelerated, augmented and more broadly reactive antibody response than does M2e peptide as measured in two different assays. Most importantly, vaccination with M2e-NSP4 caused a significant decrease in lung virus load early after challenge with influenza A virus and maintained its efficacy against a lethal challenge even at very low vaccine doses. Based on the results presented in this study M2e-NSP4 merits further investigation as a candidate for or as a component of a universal influenza A vaccine.
format article
author Anne-Marie Carola Andersson
Kjell O Håkansson
Benjamin Anderschou Holbech Jensen
Dennis Christensen
Peter Andersen
Allan Randrup Thomsen
Jan Pravsgaard Christensen
author_facet Anne-Marie Carola Andersson
Kjell O Håkansson
Benjamin Anderschou Holbech Jensen
Dennis Christensen
Peter Andersen
Allan Randrup Thomsen
Jan Pravsgaard Christensen
author_sort Anne-Marie Carola Andersson
title Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
title_short Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
title_full Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
title_fullStr Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
title_full_unstemmed Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
title_sort increased immunogenicity and protective efficacy of influenza m2e fused to a tetramerizing protein.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb9
work_keys_str_mv AT annemariecarolaandersson increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT kjellohakansson increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT benjaminanderschouholbechjensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT dennischristensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT peterandersen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT allanrandrupthomsen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
AT janpravsgaardchristensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein
_version_ 1718422062584823808